Merete Lund Hetland

Professor

University of Copenhagen

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Merete Lund Hetland is a Professor at the University of Copenhagen, Denmark. Her research primarily focuses on treatment response in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis, exploring various therapeutic interventions and patient-reported outcomes. Recent studies include investigations into treatment effectiveness, patient biomarker research, and the implications of glucocorticoid use in arthritis management.

Articles (26)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (30)

Anne Gitte Loft

Aarhus University

DENMARK

Merete Lund Hetland

Research Interests

Explore related searches

Contact this professor

About

Articles (26)

Sex differences in treatment response in patients with rheumatoid arthritis treated with tumour necrosis factor inhibitor: a cohort study from the DANBIO registry

Interchangeability of patient pain, fatigue and global scores in patients with spondyloarthritis - a registry-based simulation study

Effectiveness of ixekizumab in 709 real-world patients with axial spondyloarthritis and psoriatic arthritis: a nationwide cohort study

Validation of patient-reported outcome measures for dactylitis, psoriatic skin and nail disease, and uveitis in patients with psoriatic arthritis in routine care

Glucocorticoid treatment in early rheumatoid arthritis is independently associated with increased PCSK9 levels: data from a randomised controlled trial

Cancer recurrence risk with bDMARD treatment in patients with rheumatoid arthritis and a history of cancer: a nationwide Danish register-based cohort study

Sociodemographic and clinical variables associated with negative illness perception in patients newly diagnosed with rheumatoid arthritis, axial spondyloarthritis, or psoriatic arthritis—a survey based cross-sectional study

Rheumatoid arthritis and risk of osteoarticular infection and death following Staphylococcus aureus bacteraemia: a nationwide cohort study

Long-term efficacy of a 2-year MRI treat-to-target strategy on disease activity and radiographic progression in patients with rheumatoid arthritis in clinical remission

Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial

Plasma haem oxygenase-1 may represent a first-in-class biomarker of oxidative stress in rheumatoid arthritis

Biological material for biomarker research in spondyloarthritis: mapping the availability in European rheumatology registries

Cancer risk with tocilizumab/sarilumab, abatacept and rituximab treatment in patients with rheumatoid arthritis: a Danish cohort study

Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies

Delayed identification of disseminated infection in a patient with rheumatoid arthritis and septic arthritis: a case report

Risk of Staphylococcus aureus bacteraemia in patients with rheumatoid arthritis and the effect of orthopaedic implants on the risk: a nationwide observational cohort study

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial

Remission, response, retention and persistence to treatment with disease-modifying agents in patients with rheumatoid arthritis: a study of harmonised Swedish, Danish and Norwegian cohorts

Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries

The effect of group-based cognitive behavioural therapy for insomnia in patients with rheumatoid arthritis

Newly diagnosed with inflammatory arthritis (NISMA)–development of a complex self-management intervention

Cancer risk in patients with rheumatoid arthritis treated with janus kinase inhibitors: a nationwide Danish register-based cohort study

Baseline serum levels of IgA anti-cyclic citrullinated protein antibodies in early rheumatoid arthritis predict radiographic progression after 11 years of treatment: a secondary analysis of the CIMESTRA study.

Correction to: Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration

Antirheumatic treatment, disease activity and risk ofStaphylococcus aureusbacteraemia in rheumatoid arthritis: a nationwide nested case–control study

Collaborators (30)

Anne Gitte Loft

Stinne Greisen

Annette de Thurah

Kim Hørslev-Petersen

Gareth Jones

Andreas Petersen

Kristian Stengaard-Pedersen

Giovanni Cagnotto

Till Uhlig

Bent Deleuran

Julie Midtgaard

Kristina Lend

Daniela Di Giuseppe

Mikkel Østergaard

Thomas Benfield

Johan Askling

Sofie Bech Vestergaard

Ronald van Vollenhoven

Line Uhrenholt

Benedicte Delcoigne

Hanne Merete Lindegaard

Mette Nørgaard

Thomas Frisell

Rasmus Westermann

Leonid Padyukov

Malene Hvid

Aida Hansen

Burkhard Möller

Mette Aadahl

Andrea Burden

Make your next move.